These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19209275)

  • 1. Treatment of Crohn's disease with colony-stimulating factors: An overview.
    Guidi L; Mocci G; Marzo M; Rutella S
    Ther Clin Risk Manag; 2008 Oct; 4(5):927-34. PubMed ID: 19209275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment.
    Agnholt J; Kelsen J; Brandsborg B; Jakobsen NO; Dahlerup JF
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):649-55. PubMed ID: 15201577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
    Däbritz J
    Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte Macrophage Colony-Stimulating Factor-Activated CD39
    Weinhage T; Däbritz J; Brockhausen A; Wirth T; Brückner M; Belz M; Foell D; Varga G
    Cell Mol Gastroenterol Hepatol; 2015 Jul; 1(4):433-449.e1. PubMed ID: 28210690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sargramostim (GM-CSF) for induction of remission in Crohn's disease.
    Roth L; Macdonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008538. PubMed ID: 22071853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
    Korzenik JR; Dieckgraefe BK
    Aliment Pharmacol Ther; 2005 Feb; 21(4):391-400. PubMed ID: 15709989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.
    Gathungu G; Zhang Y; Tian X; Bonkowski E; Rowehl L; Krumsiek J; Nix B; Chalk C; Trapnell B; Zhu W; Newberry R; Denson L; Li E
    World J Gastroenterol; 2018 Feb; 24(5):623-630. PubMed ID: 29434451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
    Denson LA; Jurickova I; Karns R; Shaw KA; Cutler DJ; Okou D; Valencia CA; Dodd A; Mondal K; Aronow BJ; Haberman Y; Linn A; Price A; Bezold R; Lake K; Jackson K; Walters TD; Griffiths A; Baldassano RN; Noe JD; Hyams JS; Crandall WV; Kirschner BS; Heyman MB; Snapper S; Guthery SL; Dubinsky MC; Leleiko NS; Otley AR; Xavier RJ; Stevens C; Daly MJ; Zwick ME; Kugathasan S
    Inflamm Bowel Dis; 2019 Feb; 25(3):547-560. PubMed ID: 30124884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor.
    Dieckgraefe BK; Korzenik JR
    Lancet; 2002 Nov; 360(9344):1478-80. PubMed ID: 12433518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells.
    Mannon PJ; Leon F; Fuss IJ; Walter BA; Begnami M; Quezado M; Yang Z; Yi C; Groden C; Friend J; Hornung RL; Brown M; Gurprasad S; Kelsall B; Strober W
    Clin Exp Immunol; 2009 Mar; 155(3):447-56. PubMed ID: 19094118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.
    Heinzelman P; Carlson SJ; Cox GN
    Protein Eng Des Sel; 2015 Oct; 28(10):461-6. PubMed ID: 25855658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.
    Chuang LS; Villaverde N; Hui KY; Mortha A; Rahman A; Levine AP; Haritunians T; Evelyn Ng SM; Zhang W; Hsu NY; Facey JA; Luong T; Fernandez-Hernandez H; Li D; Rivas M; Schiff ER; Gusev A; Schumm LP; Bowen BM; Sharma Y; Ning K; Remark R; Gnjatic S; Legnani P; George J; Sands BE; Stempak JM; Datta LW; Lipka S; Katz S; Cheifetz AS; Barzilai N; Pontikos N; Abraham C; Dubinsky MJ; Targan S; Taylor K; Rotter JI; Scherl EJ; Desnick RJ; Abreu MT; Zhao H; Atzmon G; Pe'er I; Kugathasan S; Hakonarson H; McCauley JL; Lencz T; Darvasi A; Plagnol V; Silverberg MS; Muise AM; Brant SR; Daly MJ; Segal AW; Duerr RH; Merad M; McGovern DP; Peter I; Cho JH
    Gastroenterology; 2016 Oct; 151(4):710-723.e2. PubMed ID: 27377463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease: an immunodeficiency?
    Folwaczny C; Glas J; Török HP
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):621-6. PubMed ID: 12840672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment options in the management of IBD - focus on colony stimulating factors.
    Barahona-Garrido J; Yamamoto-Furusho JK
    Biologics; 2008 Sep; 2(3):501-4. PubMed ID: 19707380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human granulocyte-macrophage colony stimulating factor (sargramostim) as an alternative therapy for fistulizing Crohn's disease.
    Magno P; Jiménez CE; Ortiz Z; Torres EA
    P R Health Sci J; 2010 Mar; 29(1):60-5. PubMed ID: 20222336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
    Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
    Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease: innate immunodeficiency?
    Yamamoto-Furusho JK; Korzenik JR
    World J Gastroenterol; 2006 Nov; 12(42):6751-5. PubMed ID: 17106921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease.
    Däbritz J; Bonkowski E; Chalk C; Trapnell BC; Langhorst J; Denson LA; Foell D
    Am J Gastroenterol; 2013 Dec; 108(12):1901-10. PubMed ID: 24145675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury.
    Kitching AR; Ru Huang X; Turner AL; Tipping PG; Dunn AR; Holdsworth SR
    J Am Soc Nephrol; 2002 Feb; 13(2):350-358. PubMed ID: 11805162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.